Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Royal Sense Ltd announces the official launch of latest products in Pharmaceutical Category

Posted On: 2024-08-28 19:54:44 (Time Zone: IST)


Royal Sense Ltd has announced the launch of its new products Opentop 40, Opentop D, Opentop L, Opentop Dsr and Cefix 200 which are available for sale from August 28, 2024.

OPENTOP 40

Details: Pantoprazole 40 mg reduces stomach acid, treating GERD and ulcers by inhibiting proton pumps. It's a proton pump inhibitor.

Description

Pantoprazole 40 mg is a medication primarily used to treat conditions related to excessive stomach acid production, such as gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and peptic ulcers. It belongs to a class of drugs known as proton pump inhibitors (PPIs), which work by blocking the proton pumps in the stomach lining that produce acid. This reduction in stomach acid helps alleviate symptoms like heartburn and promotes the healing of the esophagus and stomach lining. Pantoprazole is typically taken orally, usually once daily, and can be prescribed for both short-term and long-term use. Common side effects may include headaches, diarrhoea, and nausea. It is important to follow the dosage prescribed by a healthcare provider to minimise potential side effects.

OPENTOP D

Details: Pantoprazole 40 mg reduces stomach acid treating GERD and ulcers by inhibiting proton pumps. It's a proton pump inhibitor, while domperidone 10 mg improves gastrointestinal motility and reduces nausea and vomiting.

Description

Pantoprazole 40 mg and domperidone 10 mg are often used together to address gastrointestinal issues. Pantoprazole is a proton pump inhibitor (PPI) that decreases stomach acid production, treating conditions like GERD, peptic ulcers, and Zollinger-Ellison syndrome. By reducing acid, it helps heal the esophagus and stomach lining and alleviates symptoms such as heartburn. Domperidone is a prokinetic agent that enhances gastrointestinal motility and helps relieve nausea and vomiting by facilitating gastric emptying and improving coordination of stomach contractions. This combination can be particularly effective for managing symptoms associated with delayed gastric emptying and acid-related disorders. Common side effects include headaches and gastrointestinal disturbances, so it's essential to use these medications under medical supervision.

CEFIX 200

Details: Cefixime 200 mg is an oral antibiotic that treats bacterial infections like pneumonia, ear infections, and gonorrhea.

Description

Cefixime 200 mg is a broad-spectrum oral antibiotic used to treat a variety of bacterial infections. It belongs to the cephalosporin class of antibiotics, which work by inhibiting bacterial cell wall synthesis, thereby killing bacteria. Cefixime is effective against infections such as pneumonia, bronchitis, ear infections, throat infections, and urinary tract infections. It is also used for treating gonorrhea. The medication is typically taken once or twice daily, depending on the infection and the patient's condition. Common side effects include diarrhea, nausea, and abdominal pain. It's important to complete the full course of treatment as prescribed, even if symptoms improve, to prevent antibiotic resistance and ensure the infection is fully eradicated. Always follow a healthcare provider's instructions when using cefixime.

OPENTOP DSR

Details: Pantoprazole 40 mg reduces stomach acid treating GERD and ulcers by inhibiting proton pumps. It's a proton pump inhibitor, while domperidone 30 mg with delayed release property improves gastrointestinal motility and reduces nausea and vomiting for extended duration.

Description

Pantoprazole 40 mg is a combination medication that includes pantoprazole and domperidone. Pantoprazole is a proton pump inhibitor (PPI) that reduces stomach acid production, helping to treat conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. Domperidone, a prokinetic agent, enhances gastrointestinal motility, reducing symptoms like nausea and vomiting. Together, they address both acid-related issues and digestive motility problems. Pantop DSR is commonly prescribed for patients experiencing symptoms related to excessive stomach acid and impaired digestion. It is usually taken orally, once daily, before meals. Common side effects may include headache, dry mouth, and gastrointestinal disturbances. It is essential to follow the prescribed dosage and consult a healthcare provider for proper usage.

OPENTOP L

Details: Opentop L combines pantoprazole 40mg and levosulpiride 75mg, reducing stomach acid and improving gastrointestinal motility, treating GERD and related symptoms.

Description:

Opentop L is a combination medication that includes pantoprazole and levosulpiride. Pantoprazole is a proton pump inhibitor (PPI) that decreases stomach acid production, effectively treating conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and ZollingerEllison syndrome. It helps in alleviating heartburn and promoting healing of the esophagus and stomach lining. Levosulpiride, a prokinetic agent, enhances gastrointestinal motility, which helps relieve symptoms such as nausea, vomiting, and abdominal discomfort by improving the movement of the digestive tract. This combination addresses both excessive acid production and motility issues. Pantop L is typically prescribed for managing symptoms associated with acid reflux and digestive disturbances. Common side effects may include headache, gastrointestinal disturbances, and dizziness. Always follow the prescribed dosage and consult a healthcare provider for proper use.

Shares of Royal Sense Limited was last trading in BSE at Rs. 145.00 as compared to the previous close of Rs. 145.95. The total number of shares traded during the day was 6000 in over 3 trades.

The stock hit an intraday high of Rs. 145.00 and intraday low of 145.00. The net turnover during the day was Rs. 870000.00.


Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

OLX and IDFC FIRST Bank Join Forces to Simplify Used Vehicle Financing

Attila Mermer Joins LatentView Analytics as Director in the EMEA Region

Lemon Tree Hotels signs a new property in Vijayawada

Avenue Supermarts Ltd opens new store at Narasaraopet, Andhra Pradesh

Nazara Technologies raises INR 900 Crores and increases stake in Sportskeeda to 91%

Century Textiles and Industries Ltd is now Aditya Birla Real Estate Ltd

Ion Exchange India Ltd bags contracts from Adani Power Ltd

BL Kashyap and Sons Ltd secures new order of Rs. 221 crores

Pudumjee Paper Products Ltd awards contract for 15.4 MW solar power project

Aurobindo Pharma Ltd to acquire balance 49% stake in GLS Pharma Ltd

Heritage Foods Ltd to set up new ice cream manufacturing facility at Shamirpet, Telangana

Apollo Microsystems Ltd shortlisted for ToT of PRACHAND Munition Hardware, receives order

SBI's Basel III Compliant Tier 2 Bond Issuance

Bondada Green Enegineering Pvt Ltd receives order from Bharti Airtel Ltd

Jupiter Wagons Ltd declares interim dividend of Rs. 1

Reliance Infrastructure Ltd reduces standalone external debt to Rs. 475 crore

Lupin Enters into a Non-Exclusive Patent Licensing Agreement with Takeda to Commercialize Vonoprazan, a Novel Gastrointestinal Drug in India

Starlineps Enterprises Ltd to invest Rs. 2.4 Mn in Fusion Klassroom Edutech Pvt Ltd

Tata Power Renewable Energy Limited secures 400 MW Hybrid Project from MSEDCL

Castrol's HDPE bottle now with 50% recycled plastic

Shelter Pharma Ltd secures order from Al-Saqr Agro

Reliance Infrastructure Ltd completes OTS with LIC

TCS Signs Deal with McDonald''s Philippines to Modernize IT Landscape for its 760+ Restaurants

Integrated Industries Limited fixes Oct 1, 2024 as record date for stock split

Suven Life Sciences Announces Positive Topline Results from Phase-2a Proof-of-Concept Signal Detection Open Label Study of Ropanicant

Sunshine Capital Ltd approves new business ventures

Awfis unveils 30,221 Sq. Ft. built-up area, Grade-A Flexible Workplace in GIFT City - Gandhinagar, Ahmedabad

Intellect launches eMACH.ai WealthForce.AI in the Middle East region

Reliance Infrastructure Ltd settles entire obligations with Edelweiss ARC

Trishakti Industries Ltd secures largest contract in its history

Eugia Steriles Pvt Ltd receives EIR from USFDA for new injectable facility

IGREL Renewables raises Rs 300 crore equity capital from marquee investors

Reliance Infrastructure Ltd settles dispute with Adani Group companies

Vidarbha Industries Power Ltd ceases to be subsidiary of Reliance Power Ltd

Upgradation of GRSE to 'Schedule A' CPSE by the Government of India

Mamaearth Strengthens Offline Presence Through Distribution in CSD Channel under Ministry of Defence Nationwide

IGREL Renewables Ltd enters into LoI with Inox Wind for execution of 550 MW of wind capacity on turnkey basis

Reliance Infrastructure Ltd updates on fund based outstanding

Resgen Ltd Expands EPR Services with Microsoft, Lenovo, Parle Agro, and Marico

Reliance Power Ltd settles claims related to Vidarbha Industries Power Ltd

Family Care Hospitals Ltd receives termination notice from landlords of hospital at Mira Road, Thane

Torrent Power receives Letter of Intent for 1,500 MW Pumped Hydro Storage Project

Ceigall India Ltd emerges L1 for Southern Ayodhya Bypass

Ahasolar Technologies Ltd receives order worth Rs. 18 lakhs

Avantel Ltd receives order from NewSpace India Ltd

Rishi Laser Ltd enters into technical collaboration with two Robot Manufacturing Companies

Vinny Overseas Limited allots 23,26,23,311 Rights Equity Shares

Mphasis appoints Ajay Arya as Head of Mergers & Acquisitions

Indo-Tech Transformers Ltd receives order worth Rs. 42.56 crores

LIC increases stake in Biocon Ltd


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020